Conmed Stock Performance
| CNMD Stock | USD 62.74 0.77 1.24% |
The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. CONMED returns are very sensitive to returns on the market. As the market goes up or down, CONMED is expected to follow. At this point, CONMED has a negative expected return of -0.26%. Please make sure to confirm CONMED's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if CONMED performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days CONMED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 1.37 | Five Day Return (1.07) | Year To Date Return (7.99) | Ten Year Return 20.26 | All Time Return 18.2 K |
Forward Dividend Yield 0.0131 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 0.8 | Dividend Date 2025-01-03 |
1 | Acquisition by Beyer Pat of 44677 shares of CONMED at 79.95 subject to Rule 16b-3 | 11/29/2024 |
2 | Conmed Corp to Present at J.P. Morgan Healthcare Conference | 01/02/2025 |
3 | Acquisition by Moller Andrew James of 5000 shares of CONMED at 71.18 subject to Rule 16b-3 | 01/27/2025 |
4 | Conmed Earnings Expected to Grow Should You Buy | 01/29/2025 |
5 | Conmed Surpasses Q4 Earnings and Revenue Estimates | 02/05/2025 |
6 | Conmed Corp Shares Gap Down to 68.605 on Feb 6 | 02/06/2025 |
7 | Disposition of 257 shares by Richard Glaze of CONMED at 65.3542 subject to Rule 16b-3 | 02/11/2025 |
8 | New Strong Sell Stocks for February 19th | 02/19/2025 |
9 | New York State Common Retirement Fund Acquires 1,143 Shares of CONMED Co. | 02/24/2025 |
| Begin Period Cash Flow | 24.3 M |
CONMED |
CONMED Relative Risk vs. Return Landscape
If you would invest 7,295 in CONMED on November 27, 2024 and sell it today you would lose (1,104) from holding CONMED or give up 15.13% of portfolio value over 90 days. CONMED is currently does not generate positive expected returns and assumes 2.1218% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than CONMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CONMED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CONMED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CONMED, and traders can use it to determine the average amount a CONMED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1202
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNMD |
Estimated Market Risk
| 2.12 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CONMED is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CONMED by adding CONMED to a well-diversified portfolio.
CONMED Fundamentals Growth
CONMED Stock prices reflect investors' perceptions of the future prospects and financial health of CONMED, and CONMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CONMED Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0432 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 2.77 B | ||||
| Shares Outstanding | 30.91 M | ||||
| Price To Earning | 188.03 X | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 1.31 B | ||||
| Gross Profit | 733.03 M | ||||
| EBITDA | 272.18 M | ||||
| Net Income | 132.42 M | ||||
| Cash And Equivalents | 33.35 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 905.78 M | ||||
| Debt To Equity | 1.45 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 31.15 X | ||||
| Cash Flow From Operations | 166.97 M | ||||
| Earnings Per Share | 4.25 X | ||||
| Market Capitalization | 1.92 B | ||||
| Total Asset | 2.31 B | ||||
| Retained Earnings | 560.28 M | ||||
| Working Capital | 361.88 M | ||||
| Current Asset | 393.34 M | ||||
| Current Liabilities | 119.72 M | ||||
About CONMED Performance
By analyzing CONMED's fundamental ratios, stakeholders can gain valuable insights into CONMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CONMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CONMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 220.48 | 137.98 | |
| Return On Tangible Assets | 0.15 | 0.08 | |
| Return On Capital Employed | 0.10 | 0.09 | |
| Return On Assets | 0.06 | 0.04 | |
| Return On Equity | 0.14 | 0.07 |
Things to note about CONMED performance evaluation
Checking the ongoing alerts about CONMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CONMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CONMED generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: New York State Common Retirement Fund Acquires 1,143 Shares of CONMED Co. |
- Analyzing CONMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CONMED's stock is overvalued or undervalued compared to its peers.
- Examining CONMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CONMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CONMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CONMED's stock. These opinions can provide insight into CONMED's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance |